Around 10% of the worldwide population was affected by chronic kidney disease fostering growth of the medical membrane market
The growing prevalence of infectious chronic diseases such as chronic kidney disease around the globe is augmenting the growth of the medical membrane market. According to the National Kidney Foundation 2018, data around 10% of the worldwide population was affected by chronic kidney disease. Moreover, growing government initiatives in research and development, development in the healthcare industry, pharmaceutical, biotechnology industry, and rising adoption of medical membranes across several industries are major factors propelling the growth of the medical membrane market. On the other hand, high capital investment for the production of membrane and surface fouling is estimated to restrict the growth of the market. The key players operating in the global medical membrane market include Nipro Corporation, Amniox, Pall Corporation, Sorin Group, Gore, Maquet Company, Merck Millipore, and others In November 2018, Merck, the vibrant science and technology company launched its n...